Paper42252000
Cell-based platforms for antiviral screening against hepatitis B virus: advantages, limitations, and future perspectives.
Shue TM and 6 others. Antiviral Res, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Cell-based platforms for antiviral screening against hepatitis B virus: advantages, limitations, and future perspectives. Papers, record 42252000. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42252000
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cell-based platforms for antiviral screening against hepatitis B virus: advantages, limitations, and future perspectives.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B virus | Major topic |
| Antiviral Agents | Major topic |
| Humans | |
| Virus Replication | |
| Drug Evaluation, Preclinical | |
| Animals | |
| Hepatocytes | |
| Hepatitis B |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DP1 DK139804 | NIDDK NIH HHS | United States | DP1DK139804 | PubMed | NIH RePORTER |
| R01 AI181682 | NIAID NIH HHS | United States | R01AI181682 | PubMed | NIH RePORTER |
| R01 AI190067 | NIAID NIH HHS | United States | R01AI190067 | PubMed | NIH RePORTER |
References122
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35508720 | Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells. | Acta Pharmacol Sin | 2022 | https://conductscience.org/library/papers/35508720 | PubMed |
| 2 | 33122050 | Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies. | J Pharm Sci | 2021 | https://conductscience.org/library/papers/33122050 | PubMed |
| 3 | 23246506 | The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. | J Hepatol | 2013 | https://conductscience.org/library/papers/23246506 | PubMed |
| 4 | 40348683 | EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. | J Hepatol | 2025 | https://conductscience.org/library/papers/40348683 | PubMed |
| 5 | 27819342 | Minicircle HBV cccDNA with a Gaussia luciferase reporter for investigating HBV cccDNA biology and developing cccDNA-targeting drugs. | Sci Rep | 2016 | https://conductscience.org/library/papers/27819342 | PubMed |
| 6 | 3029758 | Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3029758 | PubMed |
| 7 | 39427481 | Long-term 3D cell culture models for hepatitis B virus studies. | Virology | 2024 | https://conductscience.org/library/papers/39427481 | PubMed |
| 8 | 6952231 | Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6952231 | PubMed |
| 9 | 39644435 | Investigational RNA Interference Agents for Hepatitis B. | BioDrugs | 2025 | https://conductscience.org/library/papers/39644435 | PubMed |
| 10 | 26085156 | Hepatitis B Virus Covalently Closed Circular DNA Formation in Immortalized Mouse Hepatocytes Associated with Nucleocapsid Destabilization. | J Virol | 2015 | https://conductscience.org/library/papers/26085156 | PubMed |
| 11 | 31658963 | A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31658963 | PubMed |
| 12 | 20645056 | The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies. | Methods Mol Biol | 2010 | https://conductscience.org/library/papers/20645056 | PubMed |
| 13 | 15331414 | Near completely humanized liver in mice shows human-type metabolic responses to drugs. | Am J Pathol | 2004 | https://conductscience.org/library/papers/15331414 | PubMed |
| 14 | 2834034 | Hepatitis B virus. The major etiology of hepatocellular carcinoma. | Cancer | 1988 | https://conductscience.org/library/papers/2834034 | PubMed |
| 15 | 9123873 | pH-independent uptake of hepatitis B virus in primary human hepatocytes. | Virology | 1997 | https://conductscience.org/library/papers/9123873 | PubMed |
| 16 | 16822173 | Recognition and signaling by toll-like receptors. | Annu Rev Cell Dev Biol | 2006 | https://conductscience.org/library/papers/16822173 | PubMed |
| 17 | 6194563 | High-frequency transfection and cytopathology of the hepatitis B virus core antigen gene in human cells. | Science | 1983 | https://conductscience.org/library/papers/6194563 | PubMed |
| 18 | 27174254 | The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely. | Sci Rep | 2016 | https://conductscience.org/library/papers/27174254 | PubMed |
| 19 | 27210429 | Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients. | J Hepatol | 2016 | https://conductscience.org/library/papers/27210429 | PubMed |
| 20 | 41714905 | Acute Severe Hepatitis B Virus Infection in Previously Vaccinated Patient during Acalabrutinib Treatment. | Emerg Infect Dis | 2026 | https://conductscience.org/library/papers/41714905 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42252000
GET https://conductscience.org/api/papers/v1/42252000/references?page=2